Hercules Evergreen Fund

Hercules Evergreen Fund LP is a specialized investment vehicle managed by Hercules Adviser LLC, a wholly-owned subsidiary of the leading venture lending firm Hercules Capital, Inc. (NYSE: HTGC). Established in 2025, the fund operates as an evergreen private credit entity that provides non-dilutive financing solutions, including venture debt and growth capital, to companies in the technology and life sciences sectors. The fund targets a broad array of healthcare subsectors, such as biotechnology, pharmaceuticals, medical devices, and diagnostics. By offering flexible capital, the Hercules Evergreen Fund helps innovative ventures reach critical clinical and commercial milestones without immediate equity dilution. It leverages the deep industry expertise and extensive network of the broader Hercules Capital platform to support high-growth, institutionally-backed companies.